UNH Stock Ownership Activity

UNITEDHEALTH GROUP INC 13F holders

17 value investing gurus have made changes to the UNITEDHEALTH GROUP INC (UNH) position according to the gurus' latest SEC quarterly report(s). UNH has been completely sold out by 2 guru(s), the number of UNH shares has been increased by 1, decreased by 14 super investor(s).

Which gurus or hedge funds are buying UNH now?

According to the latest SEC filing(s) UNITEDHEALTH GROUP INC (UNH) has been bought by Ronald Muhlenkamp - Muhlenkamp & Co (added shares +0.18%).

To see more about who is investing in UNITEDHEALTH GROUP INC (UNH), please go to the UNH ownership page.

2022 Q2 (16 results)
Ronald Muhlenkamp
+0.18%
+43
+0.01%
5.90%
David Rolfe
-1.15%
-730
-0.06%
5.54%
Ravenel Boykin Curry IV
-1.18%
-34,388
-0.08%
6.41%
Eric H. Schoenstein
-3.13%
-36,013
-0.15%
4.74%
V. D. Dodge, E. M. Cox
-3.72%
-96,100
-0.06%
1.53%
Robert Olstein
-4.76%
-500
-0.04%
0.77%
Daniel Loeb
-5.79%
-35,000
-0.43%
6.93%
Stephen Mandel
-7.54%
-65,266
-0.32%
3.88%
John Armitage
-8.44%
-138,007
-0.48%
5.19%
David Tepper
-10.71%
-18,000
-0.58%
4.84%
Robert Torray
-13.63%
-4,121
-0.70%
4.42%
David M. Polen
-22.49%
-846,099
-1.15%
3.96%
Ruane, Cunniff & Goldfarb
-25.40%
-158,384
-2.53%
7.43%
Glenn Greenberg
-30.65%
-1,090
-0.02%
0.04%
Ole Andreas Halvorsen
-100.00%
-76,910
-0.18%
0.00%
Francois Rochon
-100.00%
-2,435
-0.08%
0.00%
Current price: $519.13 1.07% AVG reported price*: $513.64
2022 Q1 (16 results)
Ole Andreas Halvorsen
buy
+76,910
+0.16%
0.00%
David Rolfe
+20.49%
+10,750
+0.77%
4.55%
Ronald Muhlenkamp
+0.35%
+85
+0.02%
4.35%
David M. Polen
-2.96%
-114,675
-0.11%
3.75%
Ravenel Boykin Curry IV
-3.45%
-103,868
-0.18%
5.00%
Robert Olstein
-4.55%
-500
-0.03%
0.67%
Ruane, Cunniff & Goldfarb
-4.69%
-30,659
-0.39%
7.88%
Andrew R. Adams
-4.75%
-29,000
-0.27%
5.45%
David Tepper
-6.15%
-11,000
-0.22%
3.43%
Eric H. Schoenstein
-8.90%
-112,365
-0.43%
4.37%
Robert Torray
-11.27%
-3,838
-0.55%
4.32%
John Armitage
-19.36%
-392,598
-1.05%
4.39%
Daniel Loeb
-23.42%
-185,000
-1.23%
4.02%
Francois Rochon
-40.07%
-1,628
-0.05%
0.00%
Stephen Mandel
-62.30%
-1,430,509
-4.34%
2.63%
Glenn Greenberg
-98.40%
-218,105
-3.28%
0.05%
Current price: $519.13 1.80% AVG reported price*: $509.97
2021 Q4 (15 results)
Daniel Loeb
+16.18%
+110,000
+0.39%
2.77%
Francois Rochon
+6.36%
+243
+0.01%
0.11%
David M. Polen
+1.85%
+70,473
+0.06%
3.27%
David Rolfe
+0.95%
+494
+0.03%
3.50%
Ronald Muhlenkamp
-0.07%
-16
-0.00%
4.27%
Eric H. Schoenstein
-0.64%
-8,100
-0.03%
4.45%
Andrew R. Adams
-0.81%
-5,000
-0.04%
5.15%
Glenn Greenberg
-1.97%
-4,460
-0.07%
3.55%
John Armitage
-2.07%
-42,950
-0.10%
4.75%
Ravenel Boykin Curry IV
-2.47%
-76,328
-0.11%
4.51%
Ruane, Cunniff & Goldfarb
-2.79%
-18,782
-0.19%
6.77%
Robert Torray
-9.73%
-3,672
-0.49%
4.53%
Stephen Mandel
-23.62%
-709,903
-1.46%
4.72%
Robert Olstein
-37.14%
-6,500
-0.39%
0.66%
Ole Andreas Halvorsen
-100.00%
-726,474
-0.82%
0.00%
Current price: $519.13 3.38% AVG reported price*: $502.14
47 of 316

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.